旅行疫苗的全球市場規模:各產品，各用途，各地區，範圍及預測

旅行疫苗市場規模及預測

2024年旅行疫苗市場規模為42.8億美元，預計2024年至2031年複合年增長率為11.50%，2031年達到94.7億美元。旅行相關疾病發生率的增加預計將推動市場成長。旅行往往涉及很高的健康風險，尤其是傳染病。因此，旅行相關疾病發生率的增加將導致全球旅行疫苗市場的投資增加，以實現更有效的疫苗開發。該報告對全球旅行疫苗市場進行了全面評估。它對關鍵細分市場、趨勢、市場推動因素、阻礙因素、競爭格局以及在市場中發揮關鍵作用的因素進行了全面分析。

旅行疫苗的全球市場推動因素

旅行疫苗市場的市場推動因素受到多種因素的影響。

海外旅行增加：

全球化和可支配收入的增加導致越來越多的人出國出差、休閒和接受教育。為了避免某些地區可能流行的疾病，旅行疫苗的需求量很大。

政府要求：

許多國家要求旅行者在進入該國之前接種某些疾病的疫苗。現行立法的修訂或在強制疫苗接種清單中增加額外疫苗接種可能會對市場產生影響。

意識不斷提高：

旅客對免疫接種等預防性醫療保健價值的認識不斷提高，推動了旅遊疫苗接種的需求。

新興傳染病：

COVID-19 病毒、伊波拉出血熱和寨卡病毒等傳染病的傳播可能會嚴重影響旅行模式，需要特定的免疫接種，並且對這些疫苗的需求不斷增加。

技術開發：

疫苗技術的發展可能有利於市場，包括透過提高疫苗接種率和患者依從性來開發更有效或更持久的疫苗。

醫療支出增加：

隨著富裕國家和發展中國家的醫療保健成本上升，更多的人將能夠購買旅遊疫苗，從而擴大市場。

旅行者的興趣日益增加：

由於擔心自己的健康和安全，越來越多的人正在尋求疫苗接種和其他預防性治療，尤其是在前往流行或地方性疾病流行的地區時。

遊客人口統計：

市場動態可能受到人口統計變數的影響，例如人口老化和來自疾病高發地區的旅行者數量的增加。

旅遊業的成長：

隨著越來越多的人訪問新目的地並參加各種活動，包括探險旅遊和醫療旅遊在內的旅遊業的擴張推動了旅行疫苗的需求。

公共衛生措施：

政府機構和國際衛生組織為促進旅客接種疫苗而進行的公共衛生運動和措施可以對市場產生積極影響。

全球旅行疫苗市場的阻礙因素

有幾個因素可能對旅行疫苗市場構成限制和課題。

昂貴：

旅行疫苗接種可能很昂貴，特別是對於前往需要多次疫苗接種的多個地點的人來說。沒有經濟能力的旅客可能會因疫苗接種和體檢的費用而感到害怕。

易於取得：

旅行疫苗可能並非到處都能買到。在某些地區，由於前往提供全面旅行免疫服務的旅行專用診所或醫療保健提供者的機會有限，免疫率可能會降低。

旅行者對疫苗猶豫不決

旅行者對疫苗接種的猶豫：旅行者對疫苗接種的猶豫以及一般免疫模式可能會影響旅行者的疫苗接種率。有些人因為擔心疫苗的有效性、安全性或必要性而選擇不接受建議的免疫接種。

物流困難：

旅行者，尤其是行程複雜或出發前時間有限的旅行者，可能會發現很難獲得旅行疫苗，而在一段時間內多次接種疫苗可能會遇到困難。

複雜的行程：

對於行程複雜的旅行者，包括前往需要接種各種疫苗的多個地點的旅行者，可能很難管理和遵守所有規定的疫苗接種，導致疫苗接種可能無法提供或可能不充分。

短途旅行：

休短假或提早下班的人可能會優先考慮其他與旅行相關的計劃，而不是接種疫苗，特別是如果他們認為自己患病的風險較低。

監理牆：

如果旅客無法及時獲得必要的疫苗，可能會遇到困難。監管障礙的例子包括簽證要求和基於疫苗接種狀況的入境限制。

缺乏教育與意識：

免疫接種的需求可能較低，因為旅客不了解免疫接種的價值以及特定地點疫苗可預防疾病的風險。

競爭優先：

如果旅客認為自己感染疫苗可預防疾病的機會很低，或者沒有足夠的時間或金錢進行旅行前治療，那麼接種疫苗可能比其他旅行選擇更可取。

傳染病爆發與旅行問題：

傳染病的爆發增加了對某些旅行疫苗的需求，但也可能導致人們完全避免旅行，而在此期間對旅行疫苗的需求通常會減少。

目錄

第1章 全球旅行疫苗市場簡介

• 市場概要
• 調查範圍
• 前提條件

第2章 摘要整理

第3章 VERIFIED MARKET RESEARCH的調查手法

• 資料探勘
• 驗證
• 第一手資料
• 資料來源一覽

第4章 全球旅行疫苗市場展望

• 概要
• 市場動態
• 促進因素
• 阻礙因素
• 機會
• 波特的五力分析
• 價值鏈分析

第5章 旅行疫苗的全球市場:各產品

• 腦膜炎疫苗
• B型肝炎疫苗
• A型肝炎疫苗
• 其他

第6章 旅行疫苗的全球市場:各用途

• 國內旅遊
• 海外旅行

第7章 旅行疫苗的全球市場:各地區

• 北美
• 美國
• 加拿大
• 墨西哥
• 歐洲
• 德國
• 英國
• 法國
• 其他歐洲
• 亞太地區
• 中國
• 日本
• 印度
• 其他亞太地區
• 全球其他地區
• 南美
• 中東·非洲

第8章 全球旅行疫苗市場:競爭情形

• 概要
• 各公司的市場排行榜
• 主要的開發策略

第9章 企業簡介

• Pfizer
• Sanofi
• GlaxoSmithKline
• Merck
• AstraZeneca
• Abbott
• Roche
• Takeda Pharmaceutical
• Valeant Pharmaceuticals
• SK Chemicals
• Hualan Biological Engineering
• Serum Institute of India

第10章 附錄

• 相關調查

Travel Vaccines Market Size And Forecast

Travel Vaccines Market size was valued at USD 4.28 Billion in 2024 and is projected to reach USD 9.47 Billion by 2031, growing at a CAGR of 11.50% from 2024 to 2031. Increased incidence of travel-related diseases is expected to drive market growth. Traveling is often associated with higher health risks, especially regarding infectious diseases. Thus, the rising incidence of travel-related diseases will lead to more investments in the global Travel Vaccines Market for the development of more effective vaccines. The Global Travel Vaccines Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Travel Vaccines Market Drivers

The market drivers for the Travel Vaccines Market can be influenced by various factors. These may include:

Growing International Travel:

More individuals are going abroad for business, pleasure, and education as a result of globalisation and increased disposable incomes. In order to avoid diseases that might be common in certain locations, this fuels the demand for travel vaccinations.

Government Requirements:

A number of nations have laws requiring visitors to be immunised against specific diseases before to entry. The market may be impacted by modifications to existing laws or by the inclusion of additional vaccinations on the list of mandatory shots.

Growing Awareness:

The demand for travel vaccinations is being driven by travellers' increasing awareness of the value of preventive healthcare measures, such as vaccinations.

Emerging Infectious Diseases:

Travel patterns can be greatly impacted by the spread of infectious diseases like the COVID-19 virus, Ebola, or Zika virus, which also makes certain vaccinations necessary, which drives up demand for those vaccines.

Technological Developments:

By increasing vaccination uptake rates and patient compliance, developments in vaccine technology, such as the creation of more potent or long-lasting vaccinations, can benefit the market.

Increasing Healthcare Expenditure:

As healthcare costs rise in rich and developing nations alike, more people will be able to buy travel vaccinations, which will lead to an expansion of the market.

Growing Traveller Concerns:

People are seeking vaccinations and other preventive treatments due to worries about their health and safety when travelling, particularly to areas where endemic diseases or outbreaks are occurring.

Traveller Demographics:

The market dynamics may be impacted by demographic variables like an ageing population or a rise in the number of visitors from areas with higher rates of disease prevalence.

Growth of the tourist Industry:

As more people travel to new places and partake in a variety of activities, the need for travel vaccinations is being driven by the tourist industry's expansion, which includes adventure and medical tourism.

Public Health efforts:

Through government agencies or international health organisations, public health campaigns and efforts that promote traveller vaccination can have a positive impact on the market.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Travel Vaccines Market Restraints

Several factors can act as restraints or challenges for the Travel Vaccines Market. These may include:

Expensive:

Vaccinations against travel can be costly, particularly for people who are visiting several places that require several shots. Some travellers may be discouraged by the cost of vaccinations and consultation costs, especially those with little funds.

Limited Accessibility:

Vaccines for travel are not always readily available everywhere. Immunisation rates may be hampered in some areas by restricted access to specialty travel clinics or medical institutions that provide a comprehensive selection of travel vaccinations.

Travellers' vaccine hesitation:

can affect the uptake of travel vaccinations, much like overall vaccination patterns. Some people may choose not to receive recommended immunisations due to worries about vaccine efficacy, safety, or perceived necessity.

Logistical Difficulties:

Travellers, particularly those with complicated itineraries or little time left before departure, may encounter logistical difficulties when administering travel vaccinations, which frequently call for several doses spread over a set period of time.

Complexity of Travel Itineraries:

It may be difficult for travellers with complex itineraries, which include trips to several locations with various vaccine needs, to navigate and comply with all prescribed vaccinations, which could result in missed or insufficient vaccinations.

Short-Term Travel:

People who take short vacations or leave early may put other travel-related plans ahead of getting vaccinated against disease, particularly if they believe their risk of illness is minimal.

Regulatory Barriers:

Travellers may encounter difficulties if they are unable to receive the necessary vaccines in a timely manner. Examples of regulatory barriers include visa requirements and entry restrictions based on vaccination status.

Lack of Education and Awareness:

There may be a low demand for vaccinations due to travellers' ignorance of the value of travel immunisations and the dangers of vaccine-preventable diseases in certain locations.

Competing Priorities:

If a traveller believes there is little chance of catching a vaccine-preventable disease or if they don't have enough time or money for pre-travel medical treatment, they may place a higher priority on other travel-related costs or preparations than getting vaccinated.

Outbreaks and Travel Concerns:

Although infectious disease outbreaks can increase demand for some travel vaccinations, they can also discourage travel altogether, which lowers demand for travel vaccinations generally during such times.

Global Travel Vaccines Market Segmentation Analysis

The Global Travel Vaccines Market is segmented on the basis of Product, Application, And Geography.

Travel Vaccines Market, By Product

• Meningococcal Vaccines
• Hepatitis B Vaccines
• Hepatitis A Vaccines
• Others

Based on Product, the market is bifurcated into Meningococcal Vaccines, Hepatitis B Vaccines, Hepatitis A Vaccines, and Others. Hepatitis A is the disease that affects people the most frequently. It is a virus that can be contracted through direct contact with an infected person or through contaminated food or water.

Travel Vaccines Market, By Application

• Domestic Travel
• Outbound Travel

Based on Application, the market is bifurcated into Domestic Travel and Outbound Travel. The outbound Travel segment dominated the market with the largest share in 2019. A trip that is outbound involves traveling abroad. The main difference is that it is done in a different nation and also includes sightseeing and touring. Many travel companies arrange excursions outside of their home countries. Additionally, domestic travel fundamentally refers to intercity travel within the same nation. Domestic air travel differs significantly from international air travel in that customs and immigration procedures are typically more streamlined and lax. Additionally, domestic services may provide fewer offerings and extras than foreign services.

Travel Vaccines Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world
• On the basis of Regional Analysis, the Global Travel Vaccines Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The United States is predicted to dominate the market for human immunizations in North America. In North America, the segments for attenuated and recombinant vaccines are projected to expand more quickly than the ones for combination vaccinations. In terms of product, the Travel Vaccines Market is expected to expand quickly. Increased vaccination demand and rising R&D spending are driving growth in the European market for traveler's vaccines.
• Asia Pacific is a booming market for travel vaccines because of the region's improving healthcare infrastructure and rising government investment in education and awareness programs. The market for travel vaccines is expanding as a result of the development of the healthcare system and the economies of the Middle East and Africa. However, there are barriers preventing the market from expanding, including accessibility concerns and a lack of patient education. There is a market opportunity for travel vaccines given that the Saudi Arabian government regularly conducts immunization campaigns for the flu, influenza, and other diseases.

Key Players

• The "Global Travel Vaccines Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as
• Pfizer, Sanofi, GlaxoSmithKline, Merck, AstraZeneca, Abbott, Roche, Takeda Pharmaceutical, Valeant Pharmaceuticals, SK Chemicals, Hualan Biological Engineering, Serum Institute of India.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide insight to the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

TABLE OF CONTENTS

1. Introduction of Global Travel Vaccines Market

• Overview of the Market
• Scope of Report
• Assumptions

2. Executive Summary

3. Research Methodology of Verified Market Research

• Data Mining
• Validation
• Primary Interviews
• List of Data Sources

4. Global Travel Vaccines Market Outlook

• Overview
• Market Dynamics
• Drivers
• Restraints
• Opportunities
• Porters Five Force Model
• Value Chain Analysis

5. Global Travel Vaccines Market, By Product

• Meningococcal Vaccines
• Hepatitis B Vaccines
• Hepatitis A Vaccines
• Others

6. Global Travel Vaccines Market, By Application

• Domestic Travel
• Outbound Travel

7. Global Travel Vaccines Market, By Geography

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• UK
• France
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Rest of Asia Pacific
• Rest of the World
• Latin America
• Middle East & Africa

8. Global Travel Vaccines Market Competitive Landscape

• Overview
• Company Market Ranking
• Key Development Strategies

9. Company Profiles

• Pfizer
• Sanofi
• GlaxoSmithKline
• Merck
• AstraZeneca
• Abbott
• Roche
• Takeda Pharmaceutical
• Valeant Pharmaceuticals
• SK Chemicals
• Hualan Biological Engineering
• Serum Institute of India

10. Appendix

• Related Research